The Cigna Group stock: RBC raises target to 346 dollars
Published on 11/19/2026 at 16:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRBC lifts target as healthcare leads
- Third-quarter adjusted earnings per share reached 7.98 dollars, while revenue rose to 73.7 billion dollars.
- Management raised its 2026 adjusted earnings outlook to at least 30.60 dollars per share.
- Pharmacy-benefit headwinds remain an important consideration for the 2027 outlook.
RBC Capital raised its price target for The Cigna Group from 337 to 346 dollars on Thursday, November 19, while keeping an Outperform rating. Investing.com attributed the move to stronger-than-expected performance at Cigna Healthcare after the third-quarter results.
The Cigna Group stock traded at 252.90 euros on Lang & Schwarz at 16:05 CET on Thursday, November 19, 2026, 2.00 percent below the Xetra close of Wednesday, November 18. The latest quote gives investors a fresh reference for the stock after the company’s earnings update and the subsequent analyst revisions.
Healthcare strength offsets pharmacy pressure
Third-quarter revenue rose to 73.7 billion dollars. Adjusted earnings per share reached 7.98 dollars, supported by Cigna Healthcare, while pharmacy-benefit operations remained a source of pressure in the outlook.
Management raised its 2026 adjusted earnings outlook to at least 30.60 dollars per share. RBC also cited the company’s expectation of at least 10 percent adjusted earnings growth from a base of roughly 30 dollars, with the pharmacy business and the company’s 2027 execution remaining important investor considerations.
Analyst view adds a new reference
RBC’s move adds a more constructive target to a mixed series of recent analyst actions. The report said the third-quarter earnings beat was driven by Cigna Healthcare and prompted RBC to update its financial model.
US equities remain in focus through Current market reports.
More news and analyses on The Cigna Group stock.
The Cigna Group at a glance
- Company: The Cigna Group
- ISIN: US1255231003
- NYSE ticker: CI
- Trading venue: Lang & Schwarz
- Price: 252.90 euros at 16:05 CET on November 19, 2026
- Daily change: 2.00 percent below the Xetra close of November 18, 2026
- Xetra close: 258.05 euros on November 18, 2026
